AGP Picks
View all

Economic News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Economic News Observer.

Press releases published on September 23, 2026

EPC Group Publishes TAR-8, the 8-Surface Tenant AI Readiness Standard for Microsoft 365 and Azure
U100 at Anuga: Redefining Clean Label Standards as a China Top Additive-Free Dried Fruits Manufacturer
Global Leading Convenience Store Snack: Why 7-Eleven, Lawson, and FamilyMart Partner with U100
Five Reputable Toner Cartridge Manufacturers in China 2026: Advancing Professional Printing Solutions
Hanmi Bank Named to Piper Sandler Sm-All Stars Class of 2026
Omnigence Research Finds Cash Rent Outperforms Profit Sharing and Revenue Royalties on a Risk-Adjusted Basis
 Nearly One in Three Peptide Questions on JustAnswer Now Involve GLP-1s or Weight Loss
East River Medical Imaging Joins The Strategic Radiology Coalition.
Astoria Investment Management Launches IQGR, the Astoria International Quality Growth Kings ETF
D.W. “Dave” Barrick Named Chairman Emeritus of SCCG Management
MATI Releases: 'El Niño: Voices of the Farmers,' Smallholder Farmers in India and Zambia on El Niño and 2026 Harvest
FDA CBER Authorizes Direct Injection of DNG64-CAR-V Gene Therapy into CSF for 2nd Patient with Leptomeningeal Disease
HR Rebooted Becomes AI Rebooted, Sharpening Its Focus on AI Governance
AI World Media Group Builds a Complete Media Company for the AI Industry
GoldHaven Closes Additional Tranche of Flow-Through Financing Bringing Total Flow-Through Proceeds to $3.0 Million
BlackRock® Canada Announces Final September Cash Distributions for the iShares® Premium Money Market ETF
Uncommon Dialogue Films’ CEO Patrick Kilpatrick Selected to Present Production Slate at Asia TV Forum & Market
Ozari Health Named Best Place to Buy Compounded Tirzepatide Online for 2026
Swarmer Signs MOU With Vectus Air Defense Systems for End-to-End Mobile Air Defense Systems
Elevar Therapeutics Announces FDA Approval of Lyrfigtu (Lirafugratinib) as Second-line Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement Treatment Option

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Economic News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.